clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Personalized Medicine
News & Features
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Bioinformatics
Single Genetic Variant Associated with Cannabis Abuse
News & Features
Illumina Prevails Against Ariosa in UK Patent Infringement Case
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Precision Medicine
MGI, Karolinska Institutet Collaborate on Translational Microbiome Research
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 5
Multimedia
All
Webinars
eBooks
Webinars
In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology
eBooks
Rethinking Rx-Dx Codevelopment
Webinars
Liquid Biopsy and ddPCR: A Match with Quality in Mind
Multimedia
Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Microfluidics
Microfluidics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Microfluidics
Circulating Tumor Cells Isolated Efficiently with New Microfluidic Device
February 26, 2019
Microfluidics
Fluidigm Partnering with Genomenon to Offer Genomic Panel Design Services
June 7, 2018
Microfluidics
Fluidigm, Ascendas Genomics to Partner on MDx Systems and Assays in...
July 28, 2017
Microfluidics
Transforming Molecular Diagnostic Point of Care with Cell Phones
February 24, 2016
Microfluidics
Barcoding Gets the Drop on Single-Cell Transcriptomes
May 26, 2015
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
![Ascendas will use Fluidigm's Biomark™ HD (pictured) and Juno™ microfluidic technologies to develop molecular diagnostic systems and assays in China. [Source: Fluidigm via Fermelo Biotec]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1179-324x160.jpeg "Fluidigm, Ascendas Genomics to Partner on MDx Systems and Assays in China")
![Wells turn blue if a particular nucleic acid molecule is present. A cell-phone image of the wells can then undergo ratiometric spectral processing to provide a quantification of target molecules. [Ismagilov Lab]](https://www.clinicalomics.com/wp-content/uploads/2019/01/532-324x160.jpeg "Transforming Molecular Diagnostic Point of Care with Cell Phones")
